Document Detail


Does correction of metabolic acidosis slow chronic kidney disease progression?
MedLine Citation:
PMID:  23380803     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
PURPOSE OF REVIEW: Most patients with chronic kidney disease (CKD) have progressive decline in glomerular filtration rate (GFR), despite current treatment practices. Recent studies support that dietary acid reduction with oral sodium based alkali or base-inducing food types add kidney protection to that provided by current kidney-protective interventions. Related studies also support that correction of metabolic acidosis with dietary acid reduction slows CKD progression. We reviewed these recent studies that show improvement in CKD parameters and slower CKD progression in response to improvement of CKD-associated metabolic acidosis with these interventions.
RECENT FINDINGS: Animal as well as human models of CKD show that alkali treatment ameliorates indices of kidney injury and also might slow GFR decline in patients with or without metabolic acidosis. These benefits have been similar with oral sodium-based alkali and base-inducing fruits and vegetables, supporting dietary acid reduction as an effective adjunct to conventional kidney-protective interventions.
SUMMARY: Recent studies suggest that metabolic acidosis mediates nephropathy progression, and its treatment with the comparatively inexpensive and well tolerated intervention of dietary acid reduction holds promise to be an additional kidney-protective strategy in CKD management.
Authors:
Nimrit Goraya; Donald E Wesson
Related Documents :
21831033 - The role of angiotensin in obesity and metabolic disease.
24465563 - (1)h nmr-based metabolite profiling of plasma in a rat model of chronic kidney disease.
9824693 - Neurodegenerative changes in the guinea pig brainstem after intratympanic injection of ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current opinion in nephrology and hypertension     Volume:  22     ISSN:  1535-3842     ISO Abbreviation:  Curr. Opin. Nephrol. Hypertens.     Publication Date:  2013 Mar 
Date Detail:
Created Date:  2013-02-05     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9303753     Medline TA:  Curr Opin Nephrol Hypertens     Country:  England    
Other Details:
Languages:  eng     Pagination:  193-7     Citation Subset:  IM    
Affiliation:
aTexas A&M College of Medicine bScott and White Healthcare, Department of Internal Medicine, Temple, Texas, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Display of Human Proinsulin on the Bacillus subtilis Spore Surface for Oral Administration.
Next Document:  Differential expression of VGLUT1 or VGLUT2 in the trigeminothalamic or trigeminocerebellar projecti...